LIVER SURGERY 2. Case 1. Med 5 Refresher Course (Surgery) 2013/14. Dr Sunny Cheung
|
|
- Madeleine Tucker
- 5 years ago
- Views:
Transcription
1 LIVER SURGERY 2 Med 5 Refresher Course (Surgery) 2013/14 24 Jun 2013 Dr Sunny Cheung Case 1 50/M Sudden onset of epigastric pain Abdominal distension Confused HR 120 BP 80/50 Haemocue = 8
2 What should you do? Shock Monitoring DDx Ix Fluid resuscitate +/- unmatched blood Blood for T&S, CBC, LRFT, Clottting Reserve FFP and Platelet (massive transfusion) SaO2 + O2 BP / pulse Foley CVP ICU Intra-abdominal bleeding AAA Ruptured HCC Massive GI Bleeding USG Contrast CT if stabilized Ruptured HCC Occurs in 3 to 15% of patients with HCC Mortality rate was high (25-75%) 12-42% patients develop liver failure during acute rupture Large and peripherally located tumor tends to rupture Postulated to be caused by vascular dysfunction Hypothesis of rupture: Rapid tumor growth and necrosis Occlusion of hepatic vein by tumor thrombi or invasion Raised intratumor pressure Lai Arch Surg 2006
3 Management Aim: Stop bleeding Correct coagulopathy Transfusion Transarterial Embolisation (TAE) Poor prognosis Advanced disease Poor liver function Beware of liver failure PVT increased bilirubin > 50 Algorithm Consider RFA / Surgery only in selected patient Definitive treatment after recovery from acute episode Lai Arch Surg 2006
4 Case 2 58/F AF on aspirin Fresh PR bleeding Increased CEA to 6 Hb 10 Colonoscopy: 3cm half-circumference sigmoid colon tumor, bx: adenocarcinoma PET-CT 4cm R lobe liver metastasis What will you do? 1) Palliative Chemotherapy 2) Colonic resection + palliative chemotherapy 3) Staged colectomy + R hepatectomy 4) Combined R hepatectomy + colectomy 5) Chemotherapy + R hepatectomy + colectomy
5 Is CRLM Curable Disease? Median survival in Chemo = 11.1 to 12.7 months Liver resection: 5-yr survival = 32% Untreated = 7.5 months Germany data Stangl R year Survival is Possible Haddad AJ Int J Surg Oncol2010
6 Adjuvant Chemo after Hepatectomy Adjuvant 5FU / Leucovorin Median survival 62.2 months 5-yr survival = 52.8% Mitry E 2008 How to Define Resectablity? Tumorfactor Past: Unilobar < 4 tumors < 5cm Confined to liver (no extrahepatic met) Current: Size, number of tumor, bilobar disease and extra-hepatic met are no longer contraindication Able to resect all tumor with negative margin leaving adequate liver reserve (future liver remnant) Defined by what will remain Daniel H HPB 2007
7 Current Concepts (1) Neoadjuvant Chemo Chemo-induced liver injury Increased morbidity after hepatectomy Delay liver resection in non-responder If clearly resectable, proceed directly to resection Adjuvant Chemo Improved PFS using perioperative chemo (FOLFOX 4), but no convincing evidence in improvement in OS Pseudo-adjuvant chemo on individual basis Downstaging Chemo Reserved for initially unresectable disease Vanishing tumor tends to recur and thus need to resect the tumor bearing part Current Concepts (2) Bilobed diseases Multiple resection Combined resection + local ablation therapy If FLR too small (< 30 / 40%) Portal vein embolisation to induce hypertrophy of FLR Wait 4 weeks before surgery +/- Chemotherapy while waiting for liver hypertrophy Staged resection Combined resection + local ablation therapy Local ablation therapy (RFA) Higher recurrence and poorer survival Reserved for unresectable tumor
8 Synchronous CRLM + Primary Tumor Classical Approach Resect primary tumor first followed by hepatectomy Combined Approach One GA session, no delay Increased operative risk by combining 2 ultramajor operations Limited to young fit patient, preferably minor liver resection (<3 segments) Limit by surgical access Laparoscopic surgery Reverse Approach liver-first Advanced liver met, risk of progression beyond curative hepatectomy after resection of primary tumor Suitable for asymptomatic primary Consider giving peri-operative chemo Patient Selection in Synchronous Disease Symptoms and potential complications of primary tumor Location of primary tumor (colon vs rectum) Extent of metastatic disease (major vs minor resection) Example 1) T3/4 CA rectum + liver met Neoadjuvant chemort for primary tumor Liver first approach then deal with primary Disadvantage: appearance of new liver lesion after hepatectomy while waiting for resection of primary tumor 2) Obstructing primary CA Relieve obstruction first
9 Case 3 F/63 Painless progressive jaundice for 1 month No fever Gallbladder not palpable USG: dilated bilateral intrahepatic ducts, gallbladder normal, no gallstone, not distended Hilar Cholangiocarcinoma (Klatskin Tumor) Radiological investigation CT / MRCP Drainage ERCP / PTBD
10 Bismuth Classification This system only defines the longitudinal extent Does not consider vascular invasion or LN Met Criteria of Unresectability Blumgart 2007
11 Pre-op Investigation MDCT Look for vessels involvement (CT portogram & arteriogram) Identify lobar atrophy Allow volumetry calculation PTBD / ERCP Obtain high quality cholangiogram for operative planning Resolve cholangitis Lower bilirubin for safer hepatectomy Improve liver hypertrophy after PVE PVE in cases with inadequate FLR Principles of Surgical Treatment R0 resection of biliary tract Preserving well-functioning liver parenchyma > 30-40% Procedures: Extrahepatic bile duct resection Hepatectomy Caudate lobectomy +- L / R / central hepatectomy Depending on biliary segment(s) involved LN Dissection hepatoduodenal ligament, superior retropancreatic & common hepatic artery If portal vein bifurcation involved Vascular resection + reconstruction in expert centre Morbidity = 54%, mortality = 2% 5yr survival = 30% Nagino et al 2010
12 Fever Despite Drainage Known Klatskin tumor on palliative biliary stenting Fever DDx: 1. Cholangitis undrained segment, block stent 2. Liver abscess 3. Resistant bacteria 4. Cholecystitis Investigation: USG, blood c/st, LRFT, CBC, Clotting Tx: Drainage / change antibiotics Case 4 70/M RUQ pain + Fever HR 110, BP Normal WCC 16 Bilirubin 35 ALP / ALT mildly elevated
13 What is the differentials? DDx: Cholangitis / Cholecystitis / Liver abscess Investigation: USG / CT Hypodense leison with rim enhancement Air-filled cavity due to gas-forming organism Organisms G-negative aerobes Klebsiella, E. Coli, Enterobacter, Proteus, Citrobacter G-positive aerobes Streptococci, Staphylococcus, Enterococci G-negative anaerobes Bacteroides, Fusobacterium G-positive anaerobes Clostridium
14 Causes HPB: RPC, cholecystitis, infected tumor, RFA, TACE Portal: GI tract pathology - Diverticulitis, appendicitis, perianal abscess - Colonic Cancer Haematogenous: Endocarditis, ENT / dental infection Association: DM Treatment Antibiotics: 4-6 week course Percutaneous drainage Work-up for underlying cause Fasting glucose Tumor marker Hepatitis serology 3-phase contrast CT MRCP / ERCP? RPC Colonoscopy / Ba Enema Drain fluid for c/st and cytology
15 Summary Ruptured HCC Resuscitation, CT, correct coagulopathy, TAE Poor prognosis Colorectal liver metastasis Potentially curable with liver resection Multimodal treatment Hilar cholangiocarcinoma Bismuth classification Complex liver surgery with bile duct resection + reconstruction Liver abscess Klebsiela + DM Drainage + antibiotics Work-up
Management of Colorectal Liver Metastases
Management of Colorectal Liver Metastases MM Bernon, JEJ Krige HPB Surgical Unit, Groote Schuur Hospital Department of Surgery, University of Cape Town 50% of patients with colorectal cancer develop liver
More informationCHOLANGIOCARCINOMA (CCA)
CHOLANGIOCARCINOMA (CCA) Deepak Hariharan MD (Research), FRCS, Locum Consultant HPB Surgeon AIM Outline essential facts & principles Present 4 cases Discuss Challenges /Controversies INTRODUCTION Most
More informationColorectal Liver Metastases Metachronous
Colorectal Liver Metastases Metachronous Professor Rowan Parks Professor of Surgical Sciences University of Edinburgh No disclosures Natural History of Unresected Untreated Colorectal Metastases Year N
More informationInterventional Radiology in Liver Cancer. Nakarin Inmutto MD
Interventional Radiology in Liver Cancer Nakarin Inmutto MD Liver cancer Primary liver cancer Hepatocellular carcinoma Cholangiocarcinoma Metastasis Interventional Radiologist Diagnosis Imaging US / CT
More informationManagement of Cholangiocarcinoma. Roseanna Lee, MD PGY-5 Kings County Hospital
Management of Cholangiocarcinoma Roseanna Lee, MD PGY-5 Kings County Hospital Case Presentation 37 year old male from Yemen presented with 2 week history of epigastric pain, anorexia, jaundice and puritis.
More informationTreatment of Colorectal Liver Metastases State of the Art
Treatment of Colorectal Liver Metastases State of the Art Eddie K. Abdalla, MD, FACS Professor and Chairman of Surgery Chief of Hepatobiliary Surgery Hilton Metropolitan Palace Hotel Beirut 16 November,
More informationMANAGEMENT OF COLORECTAL METASTASES. Robert Warren, MD. The Postgraduate Course in General Surgery March 22, /22/2011
MANAGEMENT OF COLORECTAL METASTASES Robert Warren, MD The Postgraduate Course in General Surgery March 22, 2011 Local Systemic LIVER TUMORS:THERAPEUTIC OPTIONS Hepatoma Cholangio. Neuroendo. Colorectal
More informationOriginal article: new surgical approaches to the Klatskin tumour
Alimentary Pharmacology & Therapeutics Original article: new surgical approaches to the Klatskin tumour T. M. VAN GULIK*, S. DINANT*, O. R. C. BUSCH*, E. A. J. RAUWS, H. OBERTOP* & D. J. GOUMA Departments
More informationThe Surgical Management of Colorectal Metastases
11th July 2017 Bowel Cancer UK The Surgical Management of Colorectal Metastases Ben Cresswell MD(Res) FRCS Consultant HPB Surgeon The Basingstoke Hepatobiliary Unit United Kingdom Surgical Management of
More informationCurrent Treatment of Colorectal Metastases. Dr. Thavanathan Surgical Grand Rounds February 1, 2005
Current Treatment of Colorectal Metastases Dr. Thavanathan Surgical Grand Rounds February 1, 2005 25% will have metastases at initial presentation 25-50% 50% will develop metastases later 40% of potentially
More informationPersonal Profile. Name: 劉 XX Gender: Female Age: 53-y/o Past history. Hepatitis B carrier
Personal Profile Name: 劉 XX Gender: Female Age: 53-y/o Past history Hepatitis B carrier Chief complaint Fever on and off for 2 days Present illness 94.10.14 Sudden onset of epigastric pain 94.10.15 Fever
More informationSurgery for hilar cholangiocirconoma
Department of Surgery University Hospital RWTH Aachen Surgery for hilar cholangiocirconoma Ulf Peter Neumann Agenda Operating on the most complex tumor in HBP Surgery Preoperative management Does the patient
More informationTrattamento chirurgico delle lesioni epatiche secondarie difficili. Adelmo Antonucci Chirurgia Oncologica e Epato-bilio-pancreatica
Trattamento chirurgico delle lesioni epatiche secondarie difficili Adelmo Antonucci Chirurgia Oncologica e Epato-bilio-pancreatica What does it mean difficult lesions? Diagnosis Treatment Small size Unfit
More informationManagement of Liver Metastasis from Colorectal Carcinoma. Aisha White, M.D. SUNY Downstate Division of Transplantation
Management of Liver Metastasis from Colorectal Carcinoma Aisha White, M.D. SUNY Downstate Division of Transplantation Management of Colorectal Liver Metastasis Epidemiology 25% of patients diagnosed
More informationHilar cholangiocarcinoma. Frank Wessels, Maarten van Leeuwen, UMCU utrecht
Hilar cholangiocarcinoma Frank Wessels, Maarten van Leeuwen, UMCU utrecht Content Anatomy Biliary strictures (Hilar) Cholangiocarcinoom Staging Biliary tract 1 st order Ductus hepatica dextra Ductus hepaticus
More informationCurrent Treatment Strategies for Hilar and Intrahepatic Cholangiocarcinoma
Current Treatment Strategies for Hilar and Intrahepatic Cholangiocarcinoma Jean-Nicolas Vauthey, MD, FACS Professor of Surgery Chief Hepato-Pancreato-Biliary Section Department of Surgical Oncology Crescent
More informationManagement of colorectal cancer liver metastases
Management of colorectal cancer liver metastases Aliakbarian M. M.D. Assistant professor of surgery Organ Transplant & Hepatopancreatobiliary Surgeon SUBJECTS The importance of surgical resection in colorectal
More informationState of the art management of Colorectal Liver Metastasis: an interplay of Chemotherapy and Surgical options
State of the art management of Colorectal Liver Metastasis: an interplay of Chemotherapy and Surgical options Ioannis S. Hatzaras, MD, MPH, FACS Assistant Professor of Surgery Division of Surgical Oncology
More informationMultidisciplinary Treatment Strategies for Primary and Metastatic Liver Cancers
Multidisciplinary Treatment Strategies for Primary and Metastatic Liver Cancers Ching-Wei D. Tzeng, M.D. Assistant Professor Surgical Oncology University of Kentucky Markey Cancer Center Affiliate Network
More informationLiverGroup.org. Case Report Form (CRF) for STAGED procedures
Case Report Form (CRF) for STAGED procedures Patient Characteristics Case number * Age * ( 18)y Gender * Male Female Race * Caucasian Asian African Other If other race, please specify Height * cm Weight
More informationResection of liver limited resectable metastases Upfront, neoadjuvant and repeat hepatectomy
Resection of liver limited resectable metastases Upfront, neoadjuvant and repeat hepatectomy Dr Chan Chung Yip MBBS, M.Med(Surgery), MD, FAMS, FRCSEd Senior Consultant and Head Department of Hepatopancreatobiliary
More informationColon Cancer Liver Metastases: Liver-Directed Therapy
Colon Cancer Liver Metastases: Liver-Directed Therapy Shishir K. Maithel, MD FACS Assistant Professor of Surgery Division of Surgical Oncology Winship Cancer Institute Emory University August 10, 2014
More informationTreatment strategy of metastatic rectal cancer
35.Schweizerische Koloproktologie-Tagung Treatment strategy of metastatic rectal cancer Gilles Mentha University hospital of Geneva Bern, January 18th, 2014 Colorectal cancer is the third most frequent
More informationProximal Bile Duct Cancer: Contemporary Management. William R. Jarnagin, MD, FACS
Proximal Bile Duct Cancer: Contemporary Management William R. Jarnagin, MD, FACS Biliary Tract Adenocarcinoma Spectrum of disease Intrahepatic (IHC) Hilar EH Gallbladder GB CBD Distal D PD Biliary Tract
More informationVesalius SCALpel : Biliary (see also: biliary/pancreatic folios) Physiology
Vesalius SCALpel : Biliary (see also: biliary/pancreatic folios) Physiology 95% of bile acids reabsorbed; colic and chenodeoxycolic primary bile acids cholecystokinin (CCK) major stimulus of gallbladder
More information6 th August 2018 Day 1 - Gallbladder & Bile duct Topic
Venue: Sterling Hospital Auditorium, Sterling Hospitals, Gurukul Road Ahmedabad, Gujarat 6 th August 2018 Day 1 - Gallbladder & Bile duct Registration(8:00am-8:15am) Inauguration(8:15am-8:30am) Welcome
More informationMANAGEMENT OF PYOGENIC LIVER ABSCESS BOYOUNG SONG, M.D. SUNY DOWNSTATE SURGERY 11/7/13
MANAGEMENT OF PYOGENIC LIVER ABSCESS BOYOUNG SONG, M.D. SUNY DOWNSTATE SURGERY 11/7/13 CASE THE PATIENT IS A 79 YEAR OLD MALE WITH 3 DAY HISTORY OF LOWER ABDOMINAL PAIN, NAUSEA WITHOUT VOMITING, CHILLS
More informationCholangiocarcinoma (Bile Duct Cancer)
Cholangiocarcinoma (Bile Duct Cancer) The Bile Duct System (Biliary Tract) A network of bile ducts (tubes) connects the liver and the gallbladder to the small intestine. This network begins in the liver
More informationSurgical management of HCC. Evangelos Prassas Hepatobiliary and Pancreatic Surgery / Liver Transplantation Kings College Hospital / London
Surgical management of HCC Evangelos Prassas Hepatobiliary and Pancreatic Surgery / Liver Transplantation Kings College Hospital / London Global distribution of HCC and staging systems WEST 1. Italy (Milan,
More informationLiver surgery for colorectal liver metastases. Keith Roberts, Consultant Liver Transplant and Liver/Pancreas Surgeon University Hospitals Birmingham
Liver surgery for colorectal liver metastases Keith Roberts, Consultant Liver Transplant and Liver/Pancreas Surgeon University Hospitals Birmingham Introduction: what do we do? UHB Liver Unit: Liver resections
More informationTechniques to Improve Resectability of Colorectal Liver Metastases Ching-Wei D. Tzeng, M.D.
Techniques to Improve Resectability of Colorectal Liver Metastases Ching-Wei D. Tzeng, M.D. Department of Surgery Grand Rounds University of Kentucky January 15, 2014 Metastatic Colorectal Cancer (CRC)
More informationHow to deal with synchronous primary and liver metastases
How to deal with synchronous primary and liver metastases Luis Sabater Ortí MD, PhD Associate Professor University of Valencia European Board Surgical Qualification HBP (EBSQ-HPB) Department of Surgery.
More informationImaging of liver and pancreas
Imaging of liver and pancreas.. Disease of the liver Focal liver disease Diffusion liver disease Focal liver disease Benign Cyst Abscess Hemangioma FNH Hepatic adenoma HCC Malignant Fibrolamellar carcinoma
More informationHow to integrate surgery in the treatment of patients with liver-only metastatic disease
How to integrate surgery in the treatment of patients with liver-only metastatic disease Luis Sabater Ortí MD, PhD Associate Professor University of Valencia European Board Surgical Qualification HBP (EBSQ-HPB)
More informationpitfall Table 1 4 disorientation pitfall pitfall Table 1 Tel:
11 687 692 2002 pitfall 1078 29 17 9 1 2 3 dislocation outflow block 11 1 2 3 9 1 2 3 4 disorientation pitfall 11 687 692 2002 Tel: 075-751-3606 606-8507 54 2001 8 27 2002 10 31 29 4 pitfall 16 1078 Table
More informationLiver surgery, acute GI tract bleeding
Semmelweis University, Faculty of Medicine, 1 st Department of Surgery Liver surgery, acute GI tract bleeding Oszkár HAHN M.D. LIVER CYST US, CT, MRI Parasite (ELISA, eosinophil, anaphylaxy) Echinococcus
More informationLiver Cancer (Hepatocellular Carcinoma or HCC) Overview
Liver Cancer (Hepatocellular Carcinoma or HCC) Overview Recent advances in liver cancer care seek to address the rising incidence of liver cancer, which has steadily increased over the past three decades.
More informationStaging & Current treatment of HCC
Staging & Current treatment of HCC Dr.: Adel El Badrawy Badrawy; ; M.D. Staging & Current ttt of HCC Early stage HCC is typically silent. HCC is often advanced at first manifestation. The selective ttt
More informationSurgical Management of Advanced Stage Colon Cancer. Nathan Huber, MD 6/11/14
Surgical Management of Advanced Stage Colon Cancer Nathan Huber, MD 6/11/14 Colon Cancer Overview Approximately 50,000 attributable deaths per year Colorectal cancer is the 3 rd most common cause of cancer-related
More informationHepatocellular Carcinoma: Diagnosis and Management
Hepatocellular Carcinoma: Diagnosis and Management Nizar A. Mukhtar, MD Co-director, SMC Liver Tumor Board April 30, 2016 1 Objectives Review screening/surveillance guidelines Discuss diagnostic algorithm
More informationJose Ramos. Role of Surgery in isolated hepatic metastasis from breast carcinoma, melanoma or sarcoma
Role of Surgery in isolated hepatic metastasis from breast carcinoma, melanoma or sarcoma Jose Ramos University of the Witwatersrand Donald Gordon Medical Centre Evolution of liver resection Better understanding
More informationGeneral summary GENERAL SUMMARY
General summary GENERAL SUMMARY In Chapter 2.1 the long-term results and prognostic factors of radiofrequency ablation (RFA) for unresectable colorectal liver metastases (CRLM) in a single center with
More informationIntraductal papillary neoplasms in the bile ducts
Intraductal papillary neoplasms in the bile ducts Seok Hwa Youn Myunghee Yoon Dong Hoon Shin Kosin University Gospel Hospital Department of general surgery Hepato-biliary-pancreatic division Introduction
More informationINTRAARTERIAL TREATMENT OF COLORECTAL LIVER METASTASES. Dr. Joan Falcó Interventional Radiology UDIAT. Hospital Universitari Parc Taulí
INTRAARTERIAL TREATMENT OF COLORECTAL LIVER METASTASES Dr. Joan Falcó Interventional Radiology UDIAT. Hospital Universitari Parc Taulí STRATEGIES FOR CRLM LIVER METASTASES Extended indications Resectable
More informationPrimary Sclerosing Cholangitis and Cholestatic liver diseases. Ahsan M Bhatti MD, FACP Bhatti Gastroenterology Consultants
Primary Sclerosing Cholangitis and Cholestatic liver diseases Ahsan M Bhatti MD, FACP Bhatti Gastroenterology Consultants I have nothing to disclose Educational Objectives What is PSC? Understand the cholestatic
More informationGallbladder Cancer and Cholangiocarcinoma. Yuman Fong, MD Upper Gastrointestinal Cancer Seminar Copenhagen, Denmark 2009
Gallbladder Cancer and Cholangiocarcinoma Yuman Fong, MD Upper Gastrointestinal Cancer Seminar Copenhagen, Denmark 2009 A.A. Blalock, Johns Hopkins Hosp. Bull. 35:391, 1924 "...in malignancy of the gallbladder,
More informationGreater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 5
Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 5 Contents 5. Assessment & Management of Liver Metastases 42 5.1. Metachronous
More informationDr Adam Bartlett. General Surgeon Senior Lecturer University of Auckland Auckland City Hospital
Dr Adam Bartlett General Surgeon Senior Lecturer University of Auckland Auckland City Hospital 11:05-11:15 Hepatic Metastectomy is Associated with Improved Survival Where is everyone? Hepatic Metastectomy
More informationCholangiocarcinoma. GI Practice Guideline. Michael Sanatani, MD, FRCPC (Medical Oncologist) Barbara Fisher, MD, FRCPC (Radiation Oncologist)
Cholangiocarcinoma GI Practice Guideline Michael Sanatani, MD, FRCPC (Medical Oncologist) Barbara Fisher, MD, FRCPC (Radiation Oncologist) Approval Date: October 2006 This guideline is a statement of consensus
More informationAfternoon Session Cases
Afternoon Session Cases Case 1 19 year old woman Presented with abdominal pain to community hospital Mild incr WBC a14, 000, Hg normal, lipase 100 (normal to 75) US 5.2 x 3.7 x 4 cm mass in porta hepatis
More informationManagement of Stage IV Colorectal Cancer: Expanding the Horizon
Management of Stage IV Colorectal Cancer: Expanding the Horizon May Tee, MD, MPH and Jan Franko, MD, PhD MercyOne Surgical Group (Mercy Surgical Affiliates) GI Oncology Conference 2019 March 1, 2019 Disclosures
More informationPrimary tumor with synchronous metastases
Metastatic colorectal cancer: special clinical situations Primary tumor with synchronous metastases Stefan Heinrich & Hauke Lang Department of General, Visceral and Transplantation Surgery University Hospital
More informationGhosts in the Machine: Jonathan B. Koea MD; FRACS. Department of Surgery Auckland Hospital Auckland New Zealand
Ghosts in the Machine: Patient Journeys Through Cancer Treatment Jonathan B. Koea MD; FRACS. Department of Surgery Auckland Hospital Auckland New Zealand Age-Standardised Cancer Incidence (100,000 population)
More informationEndoscopic Management of Biliary Strictures. Sammy Ho, MD Director of Pancreaticobiliary Services and Endoscopic Ultrasound Montefiore Medical Center
Endoscopic Management of Biliary Strictures Sammy Ho, MD Director of Pancreaticobiliary Services and Endoscopic Ultrasound Montefiore Medical Center Malignant Biliary Strictures Etiologies: Pancreatic
More informationManagement of Patients with Suspected Cholangiocarcinoma CLINICAL GUIDELINES
London Cancer Hepatic Pancreatic and Biliary (HPB) Faculty Management of Patients with Suspected Cholangiocarcinoma CLINICAL GUIDELINES JULY 2014 This operational policy is agreed and accepted by: Designated
More informationCholangiocellular carcinoma. Dr. med. Henrik Csaba Horváth PhD
Cholangiocellular carcinoma Dr. med. Henrik Csaba Horváth PhD Acalculous biliary diseases April 12, 2017 2 Cholangiocarcinoma A slow growing malignancy of the biliary tract which tend - to infiltrate locally
More informationContemporary Imaging of Biliary Malignancy and Preoperative Evaluation
Contemporary Imaging of Biliary Malignancy and Preoperative Evaluation Linda Pantongrag-Brown, MD Advanced Diagnostic Imaging, Ramathibodi Hospital, Bangkok, Thailand Malignancy of biliary tract Cholangiocarcinoma
More informationState of the Art: Colorectal Cancer Liver Metastasis Dr. Iain Tan
State of the Art: Colorectal Cancer Liver Metastasis Dr. Iain Tan Consultant GI Medical Oncologist National Cancer Centre Singapore Clinician Scientist, Genome Institute of Singapore OS (%) Overall survival
More informationR.Sotoudehmanesh, MD Professor of Gastroenterology Digestive Disease Research Institute Tehran University of Medical Sciences Pancreatobiliary
R.Sotoudehmanesh, MD Professor of Gastroenterology Digestive Disease Research Institute Tehran University of Medical Sciences Pancreatobiliary /Advanced Endoscopy group Most common biliary malignancy and
More informationGALLBLADDER CANCER. Lidie M. Lajoie MD Downstate Surgery M&M July 21, 2011
GALLBLADDER CANCER Lidie M. Lajoie MD Downstate Surgery M&M July 21, 2011 Agenda Case Presentation Epidemiology Pathogenesis & Pathology Staging Presentation & Diagnosis Stage-wise Management Outcomes/Prognosis
More informationAggressive surgery in the multimodality treatment of liver metastases from colorectal cancer
Journal of BUON 12: 209-213, 2007 2007 Zerbinis Medical Publications. Printed in Greece ORIGINAL ARTICLE Aggressive surgery in the multimodality treatment of liver metastases from colorectal cancer N.
More informationTREATMENT FOR HCC AND CHOLANGIOCARCINOMA. Shawn Pelletier, MD
TREATMENT FOR HCC AND CHOLANGIOCARCINOMA Shawn Pelletier, MD Treatment for HCC Treatment strategies Curative first line therapy Thermal ablation vs Resection vs Transplant Other first line therapies TACE
More informationEvaluation and Management of Refractory Biliary Stricture. J. David Horwhat, MD, FACG Director of Endoscopy Lancaster Gastroenterology, Inc.
Evaluation and Management of Refractory Biliary Stricture J. David Horwhat, MD, FACG Director of Endoscopy Lancaster Gastroenterology, Inc Outline What defines a refractory biliary stricture Endoscopic
More informationHepatobiliary and Pancreatic Malignancies
Hepatobiliary and Pancreatic Malignancies Gareth Eeson MD MSc FRCSC Surgical Oncologist and General Surgeon Kelowna General Hospital Interior Health Consultant, Surgical Oncology BC Cancer Agency Centre
More informationLocoregional Therapy for Hepatoma
Locoregional Therapy for Hepatoma Robert D. Crane, MD Interventional Radiology Virginia Mason How do we know a liver mass is HCC? HCC : Bx Of pts getting liver transplant only ~ 5% had Bx to establish
More informationCholangiocarcinoma: Radiologic evaluation and interventions
November 2014 Cholangiocarcinoma: Radiologic evaluation and interventions Colin Nevins, Harvard Medical School Year III Agenda Initial course and work-up Endoscopic retrograde cholangiopancreatography
More informationMultiple Primary Quiz
Multiple Primary Quiz Case 1 A 72 year old man was found to have a 12 mm solid lesion in the pancreatic tail by computed tomography carried out during a routine follow up study of this patient with adult
More informationRadiation Therapy for Liver Malignancies
Outline Radiation Therapy for Liver Malignancies Albert J. Chang, M.D., Ph.D. Department of Radiation Oncology, UCSF March 23, 2014 Rationale for developing liver directed therapies Liver directed therapies
More informationHepatobiliary Malignancies Retrospective Study at Truman Medical Center
Hepatobiliary Malignancies 206-207 Retrospective Study at Truman Medical Center Brandon Weckbaugh MD, Prarthana Patel & Sheshadri Madhusudhana MD Introduction: Hepatobiliary malignancies are cancers which
More informationIs it possible to cure patients with liver metastases? Taghizadeh Ali MD Oncologist, MUMS
Is it possible to cure patients with liver metastases? Taghizadeh Ali MD Oncologist, MUMS Survival Rates of by Stage of Adenocarcinoma of the Colon Liver Resection New Perspective Colorectal cancer liver
More informationPancreatic Cancer. BIOLOGY: Not well defined (genetic and enviromental factors) CLINICAL PRESENTATION: Abd pain, jaundice, weight loss.
EloreMed Editor: Le Wang, MD, PhD Date of Update: 2/6/2018 UpToDate: Liposomal irinotecan (Onivyde) plus FU/LV is now approved for gemcitabine-refractory metastatic pancreatic cancer and recommended by
More informationDisclosures. Extra-hepatic Biliary Disease and the Pancreas. Objectives. Pancreatitis 10/3/2018. No relevant financial disclosures to report
Extra-hepatic Biliary Disease and the Pancreas Disclosures No relevant financial disclosures to report Jeffrey Coughenour MD FACS Clinical Associate Professor of Surgery and Emergency Medicine Division
More informationApproach to the Biliary Stricture
Approach to the Biliary Stricture ACG Eastern Postgraduate Course Washington DC June 8, 2014 Steven A. Edmundowicz MD FASGE Chief of Endoscopy Division of Gastroenterology Professor of Medicine Disclosures
More informationCelsion Symposium New Paradigms in HCC Staging: HKLC vs. BCLC Staging
Celsion Symposium New Paradigms in HCC Staging: HKLC vs. BCLC Staging Ronnie T.P. Poon, MBBS, MS, PhD Chair Professor of Hepatobiliary and Pancreatic Surgery Chief of Hepatobiliary and Pancreatic Surgery
More informationTIMOTHY M. PAWLIK, RICHARD D. SCHULICK, MICHAEL A. CHOTI
The Oncologist Hepatobiliary Expanding Criteria for Resectability of Colorectal Liver Metastases TIMOTHY M. PAWLIK,RICHARD D. SCHULICK,MICHAEL A. CHOTI Department of Surgery, Johns Hopkins University School
More informationManagement of biliary injury after laparoscopic cholecystectomy N. Dayes Kings County Hospital Center & Long Island College Hospital 8/19/2010
Management of biliary injury after laparoscopic cholecystectomy N. Dayes Kings County Hospital Center & Long Island College Hospital 8/19/2010 Case Presentation 30 y.o. woman with 2 weeks of RUQ abdominal
More informationTratamiento endoscópico de la CEP. En quien como y cuando?
Tratamiento endoscópico de la CEP. En quien como y cuando? Andrés Cárdenas, MD, MMSc, PhD, AGAF, FAASLD GI / Liver Unit, Hospital Clinic Institut de Malalties Digestives i Metaboliques University of Barcelona
More informationSurgical anatomy of the biliary tract
HPB, 2008; 10: 7276 REVIEW ARTICLE Surgical anatomy of the biliary tract DENIS CASTAING Centre hépato-biliaire, Hôpital Paul Brousse, Assistance Publique- Hôpitaux de Paris, Université Paris XI, Paris,
More informationBile Duct Injury during Lap Chole. Bile Duct Injury during cholecystectomy TOPICS. 1. Prevalence, mechanisms, prevention and diagnosis
Bile Duct Injury during cholecystectomy Catherine HUBERT Jean-Fran François GIGOT Benoît t NAVEZ Division of Hepato-Biliary Biliary-Pancreatic Surgery Department of Abdominal Surgery and Transplantation
More informationGeneral Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons
General Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons MODULE TITLE: UPPER GI & HPB - HEPATIC, PANCREATIC & BILIARY
More informationLiver Tumors. Prof. Dr. Ahmed El - Samongy
Liver Tumors Prof. Dr. Ahmed El - Samongy Objective 1. Identify the most important features of common benign liver tumors 2. Know the risk factors, diagnosis, and management of hepatocellular carcinoma
More informationMetastatic Liver Cancer
4 Metastatic Liver Cancer ANDREW J. SMITH, MD, FRCSC RONALD P. DEMATTEO, MD YUMAN FONG, MD, FACS LESLIE H. BLUMGART, MD, FACS, FRCS (ENG, EDIN, GLAS) The management of hepatic metastases has become more
More informationLiver and Pancreatic Case discussion
The Royal Marsden Liver and Pancreatic Case discussion Dr Ian Chau Consultant Medical Oncologist The Royal Marsden 77 year old gentleman with 2 months history of vague abdominal ache and clinically finding
More informationEarly management of complicated gallstones and acute pancreatitis
Early management of complicated gallstones and acute pancreatitis A/Prof Richard Cade George Kalogeropoulos ( Fellow) HPB/Upper GI Unit Eastern Health, Melbourne biliary colic/acute cholecystitis common
More informationUpdate in abdominal Surgery in cirrhotic patients
Update in abdominal Surgery in cirrhotic patients Safi Dokmak HBP department and liver transplantation Beaujon Hospital, Clichy, France Cairo, 5 April 2016 Cirrhosis Prevalence in France (1%)* Patients
More informationThe Fellowship Council And The American Hepato-Pancreatico Biliary Association
The Fellowship Council And The American Hepato-Pancreatico Biliary Association Advanced GI Surgery Curriculum for Hepato-Pancreatic & Biliary Surgery Fellowship 1. Introduction The purpose of Fellowship
More informationCase Report In Situ Split of the Liver When Portal Venous Embolization Fails to Induce Hypertrophy: A Report of Two Cases
Case Reports in Surgery Volume 2013, Article ID 238675, 4 pages http://dx.doi.org/10.1155/2013/238675 Case Report In Situ Split of the Liver When Portal Venous Embolization Fails to Induce Hypertrophy:
More informationBiliary tree dilation - and now what?
Biliary tree dilation - and now what? Poster No.: C-1767 Congress: ECR 2012 Type: Educational Exhibit Authors: I. Ferreira, A. B. Ramos, S. Magalhães, M. Certo; Porto/PT Keywords: Pathology, Diagnostic
More informationRokitansky-Aschoff sinuses are epithelial invaginations in the gallbladder wall that from as a result of increased gallbladder pressures.
Anatomy The complexity of the biliary tree can be broken down into much simpler segments. The intrahepatic ducts converge to form the right and left hepatic ducts which exit the liver and join to become
More informationManagement of Rare Liver Tumours
Gian Luca Grazi Hepato-Biliary-Pancreatic Surgery National Cancer Institute Regina Elena Rome Fibrolamellar Carcinoma Mixed Hepato Cholangiocellular Carcinoma Hepatoblastoma Carcinosarcoma Primary Hepatic
More informationHepato-Pancreatico-Biliary Surgery. Dr. Ankur J. Shah. MS, DNB, MNAMS, MRCSEd (UK), FRCS (UK)
Hepato-Pancreatico-Biliary Surgery Dr. Ankur J. Shah MS, DNB, MNAMS, MRCSEd (UK), FRCS (UK) Consultant Hepato-Pancreatico-Biliary and Liver Transplant Surgeon Ansh Liver Clinic Prevention to Cure Address
More informationNavigating the Biliary Tract with CT & MR: An Imaging Approach to Bile Duct Obstruction
Navigating the Biliary Tract with CT & MR: An Imaging Approach to Bile Duct Obstruction Ann S. Fulcher, MD Medical College of Virginia Virginia Commonwealth University Richmond, Virginia Objectives To
More informationITALIAN SURGICAL SOCIETY ENDOCRINE SURGERY SCHOOL LIVER METASTASIS FROM NEUROENDOCRINE TUMORS
ITALIAN SURGICAL SOCIETY ENDOCRINE SURGERY SCHOOL LIVER METASTASIS FROM NEUROENDOCRINE TUMORS Gennaro Favia Liver metastasis from NETs Incidence 75% in NETs Knox CD, J Gastroint Surg 2006 .but 28-45% cases
More informationMalignant Focal Liver Lesions
Malignant Focal Liver Lesions Other Than HCC Pablo R. Ros, MD, MPH, PhD Departments of Radiology and Pathology University Hospitals Cleveland Medical Center Case Western Reserve University Pablo.Ros@UHhospitals.org
More informationACUTE CHOLANGITIS AS a result of an occluded
Digestive Endoscopy 2017; 29 (Suppl. 2): 88 93 doi: 10.1111/den.12836 Current status of biliary drainage strategy for acute cholangitis Endoscopic treatment for acute cholangitis with common bile duct
More informationSTRICTURES OF THE BILE DUCTS Session No.: 5. Andrea Tringali Digestive Endoscopy Unit Catholic University Rome - Italy
STRICTURES OF THE BILE DUCTS Session No.: 5 Andrea Tringali Digestive Endoscopy Unit Catholic University Rome - Italy Drainage of biliary strictures. The history before 1980 Surgical bypass Percutaneous
More informationGI Tumor Board 3/8/2018. Case #1 IDEA. Case #1 Question #1 What is the next step in management?
GI Tumor Board Edward Kim George Poultsides Naseem Esteghamat Kenzo Hirose May Cho Alan Venook Arta Monjazeb Margaret Tempero George Fisher Andrew Ko Daniel Chang Thomas Semrad Sisi Haraldsdottir Case
More informationPancreatic Cancer Where are we?
Pancreatic Cancer Treatment Approaches & Options Pancreatic Cancer Action Network OUMC 9/22/2016 Russell G. Postier, MD Pancreatic Cancer Where are we? Estimated 2016 data 3% of cancer cases 7% of cancer
More informationState of the Art Imaging for Hepatic Malignancy: My Assignment
State of the Art Imaging for Hepatic Malignancy: My Assignment CT vs MR vs MRCP Which one to choose for HCC vs Cholangiocarcinoma What special protocols to use for liver tumors Role of PET and Duplex US
More informationHepatocellular Carcinoma: A major global health problem. David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center
Hepatocellular Carcinoma: A major global health problem David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center Hepatocellular Carcinoma WORLDWIDE The #2 Cancer Killer Overall cancer
More information